samedan logo
home > pmps > autumn 2021 > pharmapack europe returns as innovation and pharma partnering flourish
Pharmaceutical Manufacturing and Packing Sourcer

Pharmapack Europe Returns as Innovation and Pharma Partnering Flourish

It goes without saying that since the last edition of Pharmapack Europe in February 2020, the world has undergone remarkable changes. But as we now gradually emerge from the pandemic, without doubt, the contributions of the pharma industry in the last year have never been more appreciated or more prominent. The speed of the vaccine development and the industry’s agility to meet the global challenges faced has given a renewed impetus to innovations.

We see increased collaboration, increased investment, more innovators developing new ideas, and an industrywide commitment to advancing healthcare at record pace. It’s an incredibly optimistic time for our exhibitors and attendees and with face-to-face meetings and events returning, there is a real hope these can act as a further catalyst to drive new ideas and growth. It’s also one of the reasons why we are so excited to again be partnering with PMPS to reach out to their like-minded and influential pharma and packaging readership. Both editorially and as an event, we share many common interests, and are challenging the industry towards innovation and a more sustainable future.

Pharmapack Europe will once again be held at the Paris Expo, Porte de Versailles, France (13-14 October) and running alongside the in-person edition will be a fourweek digital platform hosted from 27 September until 22 October. The event is renowned in pharma as an event with a true community feel and, after the last year of limited contact, there is a great deal of excitement about sourcing, networking, and collaborating in person again – it’s the lifeblood of the industry to build business connections.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

Sherma Ellis Daal
Brand Manager at Pharmapack Europe

Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera wins Pharmapack Award in Connected Devices and Wearables category with its body injector platform Symbioze

Symbioze, the smart, high volume and sustainable on-body injector platform developed by Nemera, wins the ‘Connected Devices and Wearables’ Award at Pharmapack 2021 On October 12th, during the Pharmapack Awards Ceremony, a team of industry experts awarded Symbioze, Nemera’s large-volume on-body injector, with the Pharmapack Award in the “Connected Devices and Wearables” category.
More info >>

White Papers

The Role of the CRO in Effective Risk-Based Monitoring


The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement